Flexible Packaging Market Surges to USD 292.08 Billion by 2031, Propelled by 4.89% CAGR - Verified Market Research®
May 07, 2024 10:15 ET
|
Verified Market Research
Lewes, Delaware, May 07, 2024 (GLOBE NEWSWIRE) -- The Global Flexible Packaging Market is projected to grow at a CAGR of 4.89% from 2024 to 2031, according to a new report published by Verified...
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
May 07, 2024 09:19 ET
|
PRISM MarketView
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
May 07, 2024 07:00 ET
|
Madrigal Pharmaceuticals, Inc.
On March 14, 2024, received U.S. FDA approval of Rezdiffra™ (resmetirom) for the treatment of patients with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosisIn...
[Latest] Global Lipid Nanoparticles Market Size/Share Worth USD 1,899.8 Million by 2033 at a 14.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 02, 2024 04:30 ET
|
Custom Market Insights
Austin, TX< USA, May 02, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Lipid Nanoparticles Market Size, Trends and Insights By Type (Nano-Structured...
Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Market
May 01, 2024 14:17 ET
|
Spherix Global Insights
EXTON, PA, May 01, 2024 (GLOBE NEWSWIRE) -- In the landscape of healthcare innovation, retinal disorders, including both inherited and degenerative diseases, have become a leading focus area for...
Mass Spectrometry Market Size to Reach USD 12.3 Billion By 2032, at 8.8% CAGR: Dimension Market Research
April 24, 2024 12:40 ET
|
Dimension Market Research
New York, April 24, 2024 (GLOBE NEWSWIRE) -- Overview The Global Mass Spectrometry Market was valued of USD 5.7 billion in 2023 which is further expected to reach USD 12.3 billion by the year...
Zylö announces the creation and spinout of Atticus Pharma Inc.
April 17, 2024 08:00 ET
|
Zylö Therapeutics
Atticus to focus on biopharma applications of the innovative ‘Powered by Z-pod®’ topical-delivery platform GREENVILLE, SC, April 17, 2024 (GLOBE NEWSWIRE) -- Zylö recently effected a spinout of...
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
April 17, 2024 08:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthritis Treatment, While Pending Launch of UCB’s Bimzelx Poised to Further Disrupt the Market
April 16, 2024 14:06 ET
|
Spherix Global Insights
EXTON, PA, April 16, 2024 (GLOBE NEWSWIRE) -- In October of 2023, the US FDA approved Novartis’ intravenous (IV) formulation of Cosentyx (secukinumab) for the treatment of psoriatic arthritis (PsA),...
SAB Biotherapeutics Provides SAB-142 Trial Update
April 16, 2024 07:15 ET
|
SAB Biotherapeutics, Inc.
SAB Biotherapeutics provides update on SAB-142 clinical trial for type 1 diabetes